Abstract
The combination of polymyxin B and rifampin resulted in an additive effect against all 12 clinical isolates of Serratia marcescens examined, including multiple-drug-resistant isolates.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bodey G. P., Stewart D. In vitro studies of BB-K8, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1973 Aug;4(2):186–192. doi: 10.1128/aac.4.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenfield S., Feingold D. S. The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens. J Infect Dis. 1970 May;121(5):555–558. doi: 10.1093/infdis/121.5.555. [DOI] [PubMed] [Google Scholar]
- Price K. E., Chisholm D. R., Misiek M., Leitner F., Tsai Y. H. Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside. J Antibiot (Tokyo) 1972 Dec;25(12):709–731. doi: 10.7164/antibiotics.25.709. [DOI] [PubMed] [Google Scholar]
- RUSSELL F. E. SYNERGISM BETWEEN SULPHONAMIDE DRUGS AND ANTIBIOTICS OF THE POLYMYXIN GROUP AGAINST PROTEUS SP. IN VITRO. J Clin Pathol. 1963 Jul;16:362–366. doi: 10.1136/jcp.16.4.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traub W. H., Craddock M. E., Raymond E. A., Fox M., McCall C. E. Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol. 1971 Sep;22(3):278–283. doi: 10.1128/am.22.3.278-283.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traub W. H., Kleber I. Studies on group A (phage tail) bacteriocins of Serratia marcescens. IV. Preliminary characterization of receptors of subgroup II bacteriocins. Zentralbl Bakteriol Orig A. 1974 Dec;229(4):490–502. [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol. 1970 Oct;20(4):630–632. doi: 10.1128/am.20.4.630-632.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Urena M. T., Barasoain I., Espinosa M., Garcia E., Portoles A. Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus. Chemotherapy. 1975;21(2):82–89. doi: 10.1159/000221850. [DOI] [PubMed] [Google Scholar]